Katharina Zimmermann

Author

Medizinische Hochschule Hannover ORCID

Also Known As

K Zimmermann, K. Zimmermann, Katharina Zimmermann, Zimmermann, Katharina

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Medizinische Hochschule Hannover Boston Children's Hospital Harvard University University of Cologne University Hospital Münster

About

Katharina Zimmermann is an author at Medizinische Hochschule Hannover specializing in medicine, cell biology, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	146
2	Cell Biology	4	4	146
3	Natural Sciences	1	1	55
4	Biochemistry	1	1	55
5	Cellular Therapies	1	1	37

Katharina Zimmermann

Publications

Citations

H-Index

Page 1

	Year	Citations
Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor Fatih Noyan, Katharina Zimmermann, Matthias Hardtke‐Wolenski, American Journal of Transplantation	2016	277
Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes Michel Tenspolde, Katharina Zimmermann, Leonie C. Weber, Journal of Autoimmunity	2019	201
Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines Katharina Zimmermann, Johannes Kuehle, Anna Christina Dragon, Cancers	2020	110
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18 Wolfgang Glienke, Anna Christina Dragon, Katharina Zimmermann, Frontiers in Immunology	2022	62
VPA response in SMA is suppressed by the fatty acid translocase CD36 Lutz Garbes, Ludwig Heesen, Irmgard Hölker, Human Molecular Genetics Epigenetic ChangeMolecular BiologyVpa ResponseEpigeneticsMolecular Signaling	2012	55
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation Anton Selich, Katharina Zimmermann, Michel Tenspolde, Stem Cell Research & Therapy	2019	55
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, Journal for ImmunoTherapy of Cancer	2020	53
Isolation of human antigen‐specific regulatory T cells with high suppressive function Fatih Noyan, Young‐Seon Lee, Katharina Zimmermann, European Journal of Immunology	2014	47
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44 Rüdiger Klapdor, Shuo Wang, Michael Morgan, Biomedicines Cd44nk CellsCell TherapyCancer ImmunosurveillanceNk Cell-mediated EradicationMedicine	2021	37
Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123 Michael Morgan, Arnold Kloos, Daniela Lenz, Viruses	2021	35

Page 1